Analyst Reco. Amgen Inc. Sao Paulo

Equities

AMGN34

BRAMGNBDR004

Market Closed - Sao Paulo Other stock markets 10:25:03 2024-06-13 am EDT			5-day change	1st Jan Change
57.22 ^BRL	-1.87%		-1.31%	+14.55%

Jun. 14	Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	DJ
Jun. 14	Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating	Jun. 14	MT
RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating	Jun. 14	MT
HSBC Adjusts Price Target on Amgen to $356 From $322	May. 20	MT
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating	May. 13	MT
ANALYST RECOMMENDATIONS : UBER, Luluemon, Airbnb, Progressive...	May. 09
Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170	May. 09	MT
Mizuho Securities Raises Amgen's Price Target to $235 From $223	May. 08	MT
North American Morning Briefing : Stock Futures -2-	May. 06	DJ
UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating	May. 03	MT
Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained	May. 03	MT
William Blair Upgrades Amgen to Outperform From Market Perform	May. 03	MT
Leerink Adjusts Price Target on Amgen to $352 From $324, Keeps Market Perform Rating	May. 03	MT
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	May. 03	RE
Barclays Upgrades Amgen to Equalweight From Underweight, Adjusts Price Target to $300 From $230	May. 03	MT
Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating	May. 03	MT
RBC Adjusts Price Target on Amgen to $328 From $332, Keeps Outperform Rating	May. 03	MT
BMO Capital Adjusts Price Target on Amgen to $355 From $336, Keeps Outperform Rating	May. 03	MT
Goldman Sachs Adjusts Price Target on Amgen to $350 From $359, Keeps Buy Rating	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating	Apr. 17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Amgen Inc. Sao Paulo

Equities

AMGN34

BRAMGNBDR004

Analyst Reco.

Filters